Treatment of epilepsy in severely disabled children with bilateral brain malformations

Yoshiaki Saito1, Kenji Sugai, Eiji Nakagawa

  • 1Department of Child Neurology, National Center Hospital for Mental, Nervous and Muscular Disorders, National Center of Neurology and Psychiatry (NCNP), Japan. saitoyo@ncnp.go.jp

Insights

Management strategies for pediatric epilepsy with bilateral cortical malformations vary by subtype. Effective treatments included adrenocorticotropic hormone for infantile spasms in Group 1 and specific antiepileptics for other seizure types, with surgery offering options for refractory cases.

Area of Science:

  • Pediatric Neurology
  • Epileptology
  • Neurodevelopmental Disorders

Background:

  • Bilateral cortical malformations present complex epilepsy syndromes in children.
  • Management strategies require tailored approaches based on specific malformation types and seizure characteristics.

Purpose of the Study:

  • To define optimal management strategies for pediatric epilepsy associated with bilateral cortical malformations.
  • To categorize patients based on neuroimaging, seizure types, and EEG patterns to guide treatment decisions.

Main Methods:

  • Retrospective review of clinical data from 23 pediatric patients with bilateral cortical malformations.
  • Classification of patients into five groups based on neuroimaging, seizure semiology, and electroencephalographic findings.
  • Evaluation of the efficacy of various medical (hormonal, antiepileptic drugs, ketogenic diet) and surgical interventions.

Main Results:

  • Different groups showed varied responses to treatments; adrenocorticotropic hormone was effective for infantile spasms in Group 1 but not Group 4.
  • Phenobarbital, zonisamide, and potassium bromide benefited tonic seizures (Groups 1-3) and erratic twitching (Group 3).
  • Refractory epilepsy in Groups 4 and 5 showed limited response to medications, with surgery (callosotomy, hemispherectomy) providing seizure control in select cases.

Conclusions:

  • Epilepsy management in children with bilateral cortical malformations necessitates a subtype-specific approach.
  • Medical and surgical interventions should be carefully selected based on the distinct clinical and neurobiological profiles of each patient group.
  • This study provides a framework for optimizing treatment choices in this challenging pediatric epilepsy population.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...